The study will assess the efficacy and safety of zorevunersen compared to sham over a 52-week treatment period.

The Brennan family will host the 7th Annual Dance for Dravet on September 26th at the Third Degree Glass Factory to raise ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...

The global Phase III EMPEROR trial (NCT06872125) will evaluate the safety and efficacy of zorevunersen, a novel antisense ...

People with Dravet syndrome experience intractable seizures throughout their lives — seizures that usually begin before they are 1 year old. What’s more, these seizures aren’t all of the ...

Dravet syndrome is a type of epilepsy that starts during a child's first year. If your child has this condition, they might have seizures that last for several minutes at a time.

Dravet syndrome is a rare, severe form of epilepsy with symptoms that begin before a child turns 15 months old (and often within the first year of life). (1) Formerly known as severe myoclonic ...

‘Dravet Syndrome – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dravet Syndrome epidemiology in the 7MM, i. e. , the ...

Because Dravet syndrome is a rare, complex medical disease that is lifelong, it’s important for families to find comprehensive care.

As heatwaves become more intense with climate change, scientists are racing to understand how extreme heat changes the way ...

Grace has Dravet syndrome, a rare and severe form of epilepsy that usually begins within the first year of life. A 2015 study estimates the condition affects up to 1 in 16,000 infants born in the ...

Grace has Dravet syndrome, a rare and severe form of epilepsy that usually begins within the first year of life. A 2015 study estimates the condition affects up to 1 in 16,000 infants born in the ...